ArticleResearch square2024

Intratumoral Fc-optimized agonistic CD40 antibody induces tumor rejection and systemic antitumor immunity in patients with metastatic cancer.

Juan C Osorio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.